Answers are grounded in this paper and cite their sources.
A series of somatostatin analogues with varying activities have been studied by 1H NMR in CD3OH at low temperature in order to find a possible structural explanation for the differentiation of biological activities. In somatostatin analogues with GH release inhibitory activity a beta-turn/beta-sheet backbone conformation is present, which is shown to be characteristic of somatostatin-derived peptides exhibiting this biological activity. On the other hand, among the analogues with antitumor activity, a deviation from these typical structural features is clearly observed, but not general conformational model can be proposed.
No takes yet. Share an insight, caveat, or question.
Jaspers et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: